Prezados (as),

Em decorrência da atual situação de pandemia do Coronavírus – COVID -19, visando preservar a saúde e bem-estar de todos os participantes do evento e da comunidade em geral, informamos que o Brain teve sua data alterada para 29 de novembro a 02 de dezembro de 2020.

Reforçamos nosso compromisso com toda a comunidade que prestigia o Brain. Nesse sentido, seguem abaixo algumas informações referentes a esta alteração:

  • Local – O novo período proposto para o evento visa termos maior segurança que a epidemia já estará controlada e que teremos as condições adequadas para realização do congresso. Estamos cientes que a cidade Sede do evento – Gramado – é muito visitada nessa época e, para minimizarmos os impactos dessa alteração aos participantes do Brain, esforços estão sendo realizados no sentido de:
    • Manutenção do valor das diárias de hospedagem – os valores das diárias anteriormente comercializadas pela agência oficial de turismo, MFM, serão mantidos e novas opções com tarifas semelhantes serão ofertadas no site do evento a partir do dia 10/04. Quem realizou a compra de hospedagem com a MFM será contatado para realização do ajuste da reserva – válido para compras individuais e corporativas. Caso tenha alguma dúvida sobre reserva de hotel escreva para: atendimento@mfmagencia.com.br 
    • Congelamento do valor de inscrições por 03 meses – para auxiliar no planejamento e organização da nova agenda dos participantes, iremos manter o valor da taxa de inscrição com desconto vigente atualmente até o dia 23/06;
    • 10% de desconto no transporte de Porto Alegre a Gramado – os participantes que adquirirem o transfer regular de Porto Alegre a Gramado com a agência oficial, MFM, receberão 10% de desconto. Para reservas e mais informações contate: transportes@mfmagencia.com.br
    • Transporte gratuito até o Centro de Convenções – em decorrência da alteração de data, o Centro de Convenções que sediará o evento será o Serra Park. O congresso oferecerá transporte gratuito diariamente saindo dos principais hotéis da cidade para o centro de convenções (ida e volta).
    • Descontos e benefícios no comércio de Gramado – Participantes do Brain terão descontos em restaurantes e demais estabelecimentos do comércio da cidade. Acompanhe nossos comunicados e redes sociais para mais detalhes sobre esses benefícios.

 

  • Inscrições – As inscrições no congresso estão abertas novamente, para se inscrever clique aqui. Para aqueles que já realizaram e efetuaram o pagamento de sua inscrição, e, infelizmente, não poderão participar do evento na nova data, a taxa de inscrição será reembolsada integralmente. Serão aceitos pedidos de reembolso no valor integral até o dia 30/04/20, após essa data, será seguida a política de reembolso oficial do evento (regras disponíveis aqui). Caso tenha alguma dúvida sobre inscrições escreva para: congressos@ccmew.com

 

  • Programa científico e palestrantes – Estamos trabalhando na atualização do programa científico para divulga-lo em breve. Para auxiliar no seu planejamento, podemos antecipar que o congresso começará dia 29/11 no início da tarde e se encerrará no final da tarde de 02/12. Ressaltamos que pretendemos seguir com o programa divulgado até o momento, alterando palestrantes ou atividades SOMENTE caso haja indisponibilidade dos convidados previamente confirmados. Fique atento aos nossos comunicados e redes sociais que o manteremos atualizados sobre o programa do congresso.  Dúvidas em relação ao programa e palestrantes contate: programa@ccmew.com
  • Trabalhos científicos – Todos os trabalhos científicos que foram submetidos até o momento, serão mantidos. Caso os autores não possam participar do Congresso na nova data estipulada e cancelem suas inscrições, terão seus trabalhos automaticamente desconsiderados. Caso tenha alguma dúvida sobre trabalhos contate trabalhos@ccmew.com

 

 

Nesse momento delicado, a colaboração é essencial para encontrarmos as melhores alternativas e superar as dificuldades, por isso, gostaríamos de agradecer a rede hoteleira da cidade de Gramado pelo esforço em garantir as melhores negociações possíveis para o evento, em especial, a Rede Laghetto, Rede Master, Rede GJP, Rede Wyndham, hotéis Bavária, Alpestre, Cercano e Vestena. Também agradecemos ao Gramado e Canela Convention & Visitours Bureau, ao Centro de Convenções Serra Park e ao Senhor João Alfredo de Castilhos Bertolucci, Prefeito da cidade de Gramado, pelo apoio à realização do evento na cidade.

Por fim, nosso agradecimento especial a todos que manifestaram sua compreensão e apoio através de mensagens enviadas pelos nossos canais de comunicação e redes sociais. Muito obrigado! Os participantes do BRAIN são os responsáveis pelo êxito do congresso, as ações tomadas são pensadas em preservar a saúde de todos e oferecer um evento inesquecível!

Seguiremos atentos e estamos à disposição no caso de dúvidas através do FALE CONOSCO.

Esperamos você em Gramado!





   acesse AQUI O SITE DO BRAIN2020>>   
ADRIAN RAINE
Adrian Raine is the Richard Perry University Professor of Criminology, Psychiatry, and Psychology at the University of Pennsylvania. His research focuses on the etiology and prevention of antisocial, criminal, and psychopathic behavior in children and adults. His latest book, The Anatomy of Violence (2013, Pantheon and Penguin), reviews the brain basis to violence. He is past-President of the Academy of Experimental Criminology, and received an honorary degree from the University of York (UK) in 2015.
AVSHALOM CASPI
Avshalom Caspi, Ph.D., is the Edward M. Arnett Professor of Psychology & Neuroscience at Duke University, and Professor of Personality Development at the Institute of Psychiatry, Psychology, & Neuroscience, King’s College London. His expertise is in longitudinal methods, developmental psychology, personality assessment, life-course epidemiology, and genomics in behavioral science.
BASTIAAN BLOEM
Professor Bas Bloem is a consultant neurologist at the Department of Neurology, Radboud University Nijmegen Medical Centre, the Netherlands. In September 2008, Professor Bloem was appointed as Professor of Neurology, with movement disorders as special area of interest. He has published over 550 publications, including over 400 peer‐reviewed international papers.
DANIELA PERANI
Daniela Perani, MD, is a Neurologist and Radiologist and Full Professor of Neuroscience at Università Vita-Salute San Raffaele. She the director of the School of Specialization in Neuropsychology in the same university and Chief Coordinator of Nuclear Medicine Neurology, in the Nuclear Medicine Unit, at IRCCS Ospedale San Raffaele. She Head of Unit in the Division of Neuroscience of IRCCS Ospedale San Raffaele and Coordinator of several National and International Research Projects in Neurology and Neuroscience. Her researches deal with in vivo neuroimaging studies of neurological disease, in particular neurodegenerative dementias, and with cognitive neuroscience.
GEORGE PAPAKOSTAS
George I. Papakostas is Associate Professor of Psychiatry at Harvard Medical School and Director of Treatment-Resistant Depression Studies in the Department of Psychiatry at Massachusetts General Hospital in Boston, Massachusetts. He is also field editor for Psychopharmacology for the World Journal of Biological Psychiatry and on the editorial board of the journal Psychiatry Research. The focus of Dr Papakostas research includes the pharmacotherapy of major depressive disorder (MDD) including treatment-resistant depression, the study of the placebo effect and its relevance to clinical trial design in MDD, and the study of clinical and biologic markers of treatment outcome in MDD.
LINDA CLARE
Professor of Clinical Psychology of Ageing and Dementia and PenARC Dementia Theme Lead. Professor Linda directs the Centre for Research in Ageing and Cognitive Health (REACH), which is a joint venture between the University of Exeter‘s Medical School and Department of Psychology, and PenARC. Linda is also the Theme Lead for the PenARC Dementia theme. Her research aims to improve the lives of older people and people who are living with dementia or other age-related neurodegenerative conditions by promoting well-being, preventing or reducing age-related disability, and improving rehabilitation and care.
MARK HALLETT
Dr. Hallett obtained his A.B. and M.D. at Harvard University, had his internship in Medicine at the Peter Bent Brigham Hospital and his Neurology training at Massachusetts General Hospital. He had fellowships in neurophysiology at the NIH and in the Department of Neurology, Institute of Psychiatry in London, where he worked with C. David Marsden. Before coming to NIH in 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women‘s Hospital in Boston and progressed to Associate Professor of Neurology at Harvard Medical School. He is currently Chief of the Medical Neurology Branch and Chief of its Human Motor Control Section. He is now Past-President of the International Federation of Clinical Neurophysiology. He has been President of the International Parkinson and Movement Disorder Society and Vice-President of the American Academy of Neurology. He served as Editor in Chief of Clinical Neurophysiology. Among many awards, in 2012 he became an Honorary Member of the American Neurological Association, and in 2014 won the Lifetime Achievement Award of the American Association of Neuromuscular and Electrodiagnostic Medicine. In 2017 he received the degree of Doctor of Medicine Honoris Causa from the University of Hamburg, and in 2018 was made an Honorary Member of the European Academy of Neurology. His research activities focus on the physiology of human voluntary movement and its pathophysiology in disordered voluntary movement and involuntary movement.
STEFANO CAPPA
Professor Stefano F. Cappa graduated in Medicine and specialized in Neurology at the University of Milan. He has spent periods of study and research at the University of Boston, the Massachusetts Institute of Technology, the Medical Research Council Cyclotron Unit of Hammersmith Hospital in London, and the Max Planck Institute for Cognitive Neuroscience in Leipzig. Since 1999 full professor of Cognitive Neuroscience at the University Vita-Salute S. Raffaele of Milan, and Director of the Unit of Neuroriabilitation of San Raffaele Turro, since 2013 professor of neurology at the IUSS of Pavia. From 2016 to 2019 Scientific Director of the IRCCS S. Giovanni di Dio Fatebenefratelli, Brescia, from 2019 affiliated to the Institute of Neurology, Mondino Foundation. Prof. Cappa‘s research activity is in the area of cognitive neurosciences, and concerns in particular the neurological bases of language, memory and social behaviour. He has published more than 350 papers in leading international neurological and neuropsychological journals, and several books, including recently "Cognitive Neurology" at Oxford University Press.
STEPHEN M. STAHL
Dr. Stahl iss professor at the University of California at San Diego and Honorary Fellow in Psychiatry at the University of Cambridge, editor-in-chief of CNS Spectrums and author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, and 52 textbooks including the best selling Stahl’s Essential Psychopharmacology, now in its fourth edition and the best selling and award winning clinical manual, Essential Psychopharmacology Prescriber’s Guide, now in its sixth edition. His books have won the British Medical Association’s Book of the Year Award and recently, first prize for best digital medical book. Recently, Dr. Stahl has published his first novel, Shell Shock , a thriller that recounts the history of PTSD (post traumatic stress disorder). Dr. Stahl has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education, the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD Psychiatry Residency Teaching Award, has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America” and was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecturer for 2013 and later the 2016 David Mrazek Award Winner of the American Psychiatric Association and gave the Mrazek Pharmacogenomics Memorial Lecture at the 2016 APA meeting.
TERRIE MOFFITT
Terrie E. Moffitt, Ph.D., is the Nannerl O. Keohane University Professor of Psychology at Duke University, and Professor of Social Development at King’s College London. Her expertise is in the areas of longitudinal methods, developmental theory, clinical mental health research, neuropsychology, and genomics in behavioral science. Her initial interest was in antisocial and criminal behavior, but she also studies depression, psychosis, and addiction. She is interested in the consequences of a lifetime of mental and behavioral disorder on processes of aging.


Realização
Gerenciamento
Agência de Turismo

Apoio